Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.

Machine learning model accurately diagnoses interstitial pneumonia, matching pulmonologist expertise and predicting mortality ...

Sarcoidosis, an inflammatory disease characterized by granuloma formation, affects various organs, most commonly the lungs.

Qureight is also enhancing clinical trial design by reducing the need for placebo arms through its Synthetic Control Arms ...

In progress, the attacking midfielder Lucas ran on the field for the first time after undergoing arthroscopy to remove ...

Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic (VEXAS) syndrome is a newly identified disorder caused by an ...

CyPath® Lung identifies incidentally found ground-glass lung nodules, leading to early diagnosis and timely treatment.

Vascularized bone grafting (VBG) is indispensable for reconstructing bony defects in maxillofacial injuries [ 1 , 2 ]. Recently, there has been an increasing trend in mandibular gunshot injuries ...

A research group from the National Cancer Research Center (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult. The ...

For a long time, physicians and scientists believed our lungs were sterile (germ-free). But modern science indicates ...

Idiopathic pulmonary fibrosis is a potentially fatal disease currently without treatment, in which lung tissue develops scarring and becomes stiff, making breathing increasingly difficult over time.

Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Diagnostic And Treatment Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.